Trials / Terminated
TerminatedNCT00272025
Treatment Resistant Bipolar Depression
Six Week Double Blind, Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Queen's University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To determine if adding Escitalopram to current mood stabilizer (MS) or atypical antipsychotic (AA) will improve in rates similar to or better than adding a placebo (inactive pill)in resistant bipolar patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram | 10mg to 20mg tablet daily for 6 weeks |
| DRUG | placebo |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2006-01-04
- Last updated
- 2015-12-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00272025. Inclusion in this directory is not an endorsement.